Tag: Cambrex

Permira Funds to Acquire Cambrex for $2,4b

cambrex
Cambrex Corporation, the leading small molecule company providing drug substance, drug product, and analytical services across the entire drug lifecycle, announced that it has signed a definitive agre...

Cambrex Completed New Process Facility in Sweden

cambrex
Cambrex Corporation, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, announced that it has completed a new 600 m2 fa...

Cambrex to Double Liquid Packaging Capacity

Cambrex Corporation, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, announced it will double the liquid packaging c...

Avista Becomes Part of Cambrex

Cambrex Corporation, a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage forms, announced that it has completed the acquisition...

Cambrex Corporation buys Avista Pharma Solutions

api
Cambrex, the leading manufacturer of small molecule innovator and generic APIs and finished dosage forms, announced it has entered into a definitive agreement to acquire Avista Pharma Solutions.

Cambrex sets up a center of excellence for API clinical supply

cambrex
Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage forms announced that it is to establish a center of ...

Cambrex broadens its capabilities by acquiring Halo Pharma

cambrex
Cambrex Corporation announced it has entered into a definitive agreement to acquire Halo Pharma, a leading dosage form CDMO for approximately $425 million.

Cambrex will expand its R&D facility in Italy

api
Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients, announced that it will expand research and development capabilities at its site in Paullo, Milan, Italy.

Cambrex upgrades its US facility using continuous flow technology

api
Cambrex, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients, announced that it has completed the installation of multiple continuous flow reactor platforms at its US facility.

Cambrex expands its North American facility

chemistry
Cambrex Corporation, the leading manufacturer of small molecule innovator and generic APIs, announced an investment to expand chemical and analytical development capabilities at its Charles City, Iowa plant

Cambrex and AstraZeneca entered a long-term manufacturing agreement

api
Cambrex Corporation held an opening ceremony with AstraZeneca at its Karlskoga, Sweden site to mark the commencement of a long-term manufacturing agreement between the two companies

Cambrex finished the expansion of API manufacturing facility in Sweden

api
Cambrex Corporation announced that it has completed the installation of new, large scale manufacturing capacity at its cGMP facility in Karlskoga, Sweden

Cambrex expanded its US facility with a $3.2 million analytical lab

lab
Cambrex Corporation announced that it is expanding its High Point, North Carolina, facility with the addition of a new $3.2 million, 11,000 sq.ft. analytical laboratory